Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 492401 - 492420 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EA01) imatinib (adm: O) | IMATINIB MESYLATE 100MG TAB | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GoldenStateMedicalSupply,Inc. |
| USA | (L01EA01) imatinib (adm: O) | IMATINIB MESYLATE 400MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GoldenStateMedicalSupply,Inc. |
| USA | (L01EB09) lazertinib | LAZCLUZE 240MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01EB09) lazertinib | LAZCLUZE 80MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01EC) b-raf serine-threonine kinase (braf) inhibitors | OJEMDA 25MG/ML SUSP,ORAL | 12ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | DayOneBiopharmaceuticals,Inc. |
| USA | (L01EC) b-raf serine-threonine kinase (braf) inhibitors | OJEMDA 100MG TAB,PKT,4 | 16 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | DayOneBiopharmaceuticals,Inc. |
| USA | (L01EC) b-raf serine-threonine kinase (braf) inhibitors | OJEMDA 100MG TAB,PKT,5 | 20 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | DayOneBiopharmaceuticals,Inc. |
| USA | (L01EC) b-raf serine-threonine kinase (braf) inhibitors | OJEMDA 100MG TAB,PKT,6 | 24 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | DayOneBiopharmaceuticals,Inc. |
| USA | (L01EK03) tivozanib (adm: O) | FOTIVDA 1.34MG CAP,ORAL | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | AveoPharmaceuticalsInc. |
| USA | (L01EK03) tivozanib (adm: O) | FOTIVDA 1.34MG CAP,ORAL | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | AveoPharmaceuticalsInc. |
| USA | (L01EK03) tivozanib (adm: O) | FOTIVDA 0.89MG CAP,ORAL | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | AveoPharmaceuticalsInc. |
| USA | (L01EK03) tivozanib (adm: O) | FOTIVDA 0.89MG CAP,ORAL | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | AveoPharmaceuticalsInc. |
| USA | (L01EL01) ibrutinib (adm: O) | IMBRUVICA 560MG TABLET | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell;Leukemia, Lymphocytic, Chronic, B-Cell | Pharmacyclics,LLC |
| USA | (L01EL01) ibrutinib (adm: O) | IMBRUVICA 560MG TABLET | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell;Leukemia, Lymphocytic, Chronic, B-Cell | Pharmacyclics,LLC |
| USA | (L01EM) phosphatidylinositol-3-kinase (pi3k) inhibitors | ITOVEBI 3MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GenentechUSA,Inc. |
| USA | (L01EM) phosphatidylinositol-3-kinase (pi3k) inhibitors | ITOVEBI 9MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GenentechUSA,Inc. |
| USA | (L01FF01) nivolumab | OPDIVO 100MG/10ML INJ | 1X10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbCompany |
| USA | (L01FF01) nivolumab | OPDIVO 10MG/ML INJ,SOLN 24ML | 24ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbCompany |
| USA | (L01FF01) nivolumab | OPDIVO 120MG VIAL | 12ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbCompany |
| USA | (L01FF01) nivolumab | OPDIVO 40MG/4ML INJ | 1X4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbCompany |
Pages
